Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGG1 | O15527 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | LIG1 | P18858 | 1/20 | 0.33 |
| ▸ | POLM | Q9NP87 | 2/20 | 0.33 |
| ▸ | POLK | Q9UBT6 | 2/20 | 0.33 |
| ▸ | POLL | Q9UGP5 | 2/20 | 0.33 |
| ▸ | POLH | Q9Y253 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8675067 | 0.80 | KMT2A (0.45) | KMT2AKDM4ENPC1MEN1RECQL | |
| SCHEMBL7971606 | 0.76 | MRGPRX4 (0.39) | KMT2AKDM4ENPSR1MEN1ALDH1A1 | |
| SCHEMBL28521500 | 0.76 | ALDH1A1 (0.49) | OGG1KMT2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL10513877 | 0.76 | CYP3A4 (0.42) | KMT2AKDM4ENPSR1MEN1LIG1 | |
| SCHEMBL8678126 | 0.76 | POLM (0.54) | KMT2AKDM4EMEN1RECQLPOLM | |
| SCHEMBL5459734 | 0.76 | TYMS (0.44) | KMT2AKDM4ENPC1LIG1ALDH1A1 | |
| SCHEMBL27395153 | 0.76 | KMT2A (0.43) | KMT2AKDM4ENPC1MEN1RECQL | |
| SCHEMBL2763295 | 0.75 | PTGDR2 (0.49) | KMT2AKDM4ENPSR1MEN1RECQL | |
| SCHEMBL878243 | 0.75 | LMNA (0.45) | KMT2AKDM4EMEN1RECQLALDH1A1 | |
| SCHEMBL29034766 | 0.75 | KDM4E (0.41) | KMT2AKDM4EMEN1RECQLLIG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100516015-C | Process for preparing alkyl 2, 2-dichloro-or dibromophenylacetates | DSM FINE CHEM AUSTRIA GMBH (AT) | 2009-07-22 | — | — | CN | disclosed |
| CN-100516015-C | Process for preparing alkyl 2, 2-dichloro-or dibromophenylacetates | DSM FINE CHEM AUSTRIA GMBH (AT) | 2009-07-22 | — | — | CN | disclosed |
| CN-1642898-A | Method for producing 2,2-dichloro or dibromo-phenyl alkyl acetates | DSM FINE CHEM AUSTRIA GMBH (AT) | 2005-07-20 | — | — | CN | disclosed |
| CN-1642898-A | Method for producing 2,2-dichloro or dibromo-phenyl alkyl acetates | DSM FINE CHEM AUSTRIA GMBH (AT) | 2005-07-20 | — | — | CN | disclosed |
| US-20050131246-A1 | Method for producing 2,2-dichloro or dibromo-phenyl alkyl acetates | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2005-06-16 | — | — | US | disclosed |
| US-20050131246-A1 | Method for producing 2,2-dichloro or dibromo-phenyl alkyl acetates | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2005-06-16 | — | — | US | disclosed |
| EP-1490322-A1 | METHOD FOR PRODUCING 2,2-DICHLORO OR DIBROMO-PHENYL ALKYL ACETATES | DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084918-A1 | METHOD FOR PRODUCING 2,2-DICHLORO OR DIBROMO-PHENYL ALKYL ACETATES | DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) | 2003-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131246-A1 | Method for producing 2,2-dichloro or dibromo-phenyl alkyl acetates | CBR1, CBR3, ADH1C | OGG1 2742/4885KMT2A 1097/4885KDM4E 3766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.